NewGenIVF updates share count and market value
NewGenIVF Group Limited reported that its total outstanding Class A shares now stand at 5,919,948, following share issuances connected to strategic share purchase agreements to acquire a 3% equity interest in K25.ai.
Rhea-AI Filing Summary
NewGenIVF Group Limited reported that its total outstanding Class A shares now stand at 5,919,948, following share issuances connected to strategic share purchase agreements to acquire a 3% equity interest in K25.ai.
Using the July 30, 2026 closing price of $0.85 per share, the company’s Market Value of Listed Securities reached US$5,031,956.
Positive
- None.
Negative
- None.
Key Figures
Outstanding Class A shares: 5,919,948 shares
Closing share price: $0.85 per share
Market Value of Listed Securities: US$5,031,956
+1 more
4 metrics
Outstanding Class A shares
5,919,948 shares
Total outstanding Class A shares now stand at this level, as reported July 31, 2026.
Closing share price
$0.85 per share
Closing trading price on July 30, 2026 used to calculate market value.
Market Value of Listed Securities
US$5,031,956
Calculated using the $0.85 closing price and current outstanding Class A shares.
Equity interest in K25.ai
3%
Equity interest NewGenIVF is acquiring in K25.ai via strategic share purchase agreements.
Key Terms
Form 6-K, foreign private issuer, strategic share purchase agreements, equity interest, +1 more
5 terms
Form 6-K regulatory
"Form 6-K REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A Form 6-K is a report that companies listed in certain countries file to provide important updates, such as financial results, corporate changes, or other significant information, to regulators and investors. It functions like an official company update or news release, helping investors stay informed about developments that could affect their investment decisions.
foreign private issuer regulatory
"REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16"
A foreign private issuer is a company organized outside the United States that meets tests showing it is primarily foreign-controlled and therefore qualifies for a different set of U.S. reporting rules. For investors, that means the company files less frequent or differently formatted disclosures with U.S. regulators and may follow home-country accounting and governance practices, so buying its stock is like dining at a well-reviewed restaurant that follows its home kitchen’s rules instead of the local menu — you get access but should check what standards apply.
equity interest financial
"agreements to acquire a 3% equity interest in K25.ai"
An equity interest is an ownership stake in a company that gives the holder a share of its assets, profits and sometimes voting power—think of owning a slice of a pie that grows or shrinks with the business. Investors care because the size and type of that stake determine how much they benefit from future gains, bear losses, receive dividends, or influence decisions, and it directly affects the value and risk of their investment.
Market Value of Listed Securities financial
"the Company’s Market Value of Listed Securities reached US$5,031,956"
Market value of listed securities is the market value of the shares a company has listed on an exchange, calculated as the closing bid price multiplied by the number of listed shares. Exchanges use it as a continued-listing standard, so a company that stays under the required minimum receives a deficiency notice and is given a set period to recover before facing delisting.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How large is NewGenIVF’s (NIVF) equity interest in K25.ai?
NewGenIVF is acquiring a 3% equity interest in K25.ai through strategic share purchase agreements. The company issued additional Class A shares in connection with these agreements, which contributed to the updated outstanding share count it reported.
What market value of listed securities did NewGenIVF (NIVF) disclose?
NewGenIVF disclosed a Market Value of Listed Securities of US$5,031,956. This figure is based on the closing trading price of $0.85 per Class A share on July 30, 2026, applied to its current outstanding share count.
AI-generated analysis. How Rhea-AI works. Not financial advice.
